Sanders Capital’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.39B Sell
7,065,628
-4,076
-0.1% -$786K 1.66% 21
2025
Q4
$1.3B Buy
7,069,704
+40,363
+0.6% +$7.08M 1.5% 22
2025
Q3
$1.08B Sell
7,029,341
-234,090
-3% -$35.4M 1.33% 23
2025
Q2
$1.02B Sell
7,263,431
-271,062
-4% -$38M 1.36% 23
2025
Q1
$1.11B Sell
7,534,493
-58,853
-0.8% -$8.51M 1.66% 21
2024
Q4
$995M Buy
7,593,346
+106,150
+1% +$14.9M 1.45% 19
2024
Q3
$1.17B Buy
7,487,196
+14,575
+0.2% +$2.35M 1.69% 21
2024
Q2
$1.17B Buy
7,472,621
+63,129
+0.9% +$9.5M 1.79% 18
2024
Q1
$1B Buy
7,409,492
+67,459
+0.9% +$8.93M 1.68% 23
2023
Q4
$989M Buy
7,342,033
+2,061,482
+39% +$268M 1.83% 21
2023
Q3
$715M Buy
+5,280,551
New +$721M 1.51% 26

Other funds holding AZN